DMYD B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Diamyd Medical is active in diabetes research. The company has developed a vaccine that contains the active ingredient and molecule GAD, a substance that has the potential to be an important part of the prevention of diabetes treatments in the future. The company has operations on a global level with the largest presence in the Nordic region. The headquarters are located in Stockholm.
Lue lisääLiikevaihto t.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Osavuosikatsaus Q3'26
Vuosikatsaus '26
Yhtiökokous '26
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
